サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1777148

慢性閉塞性肺疾患（COPD）治療薬の世界市場、2025年～2029年

Global Chronic Obstructive Pulmonary Disease Drugs Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 229 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
慢性閉塞性肺疾患（COPD）治療薬の世界市場、2025年～2029年
出版日: 2025年07月17日
発行: TechNavio
ページ情報: 英文 229 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

慢性閉塞性肺疾患（COPD）治療薬市場は2024-2029年に78億4,100万米ドル、予測期間中のCAGRで6.4％の成長が予測されています。

当レポートでは、慢性閉塞性肺疾患（COPD）治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、COPDの有病率の上昇、強力なパイプラインと新薬の承認、合剤に対する需要の高まりによって牽引されています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比 5.8%
CAGR 6.4%
増分額 78億4,100万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間の慢性閉塞性肺疾患（COPD）治療薬市場の成長を促進する主な要因の一つとして、治療的アプローチにおける調査拡大を挙げています。また、ドラッグデリバリーデバイスの進歩や吸入療法の拡大は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024-2029

第5章 市場規模実績

  • 慢性閉塞性肺疾患（COPD）治療薬の世界市場 2019-2023
  • 製品別セグメント分析 2019-2023
  • 流通チャネル別セグメント分析 2019-2023
  • 投与経路別セグメント分析 2019-2023
  • 疾患タイプ別セグメント分析 2019-2023
  • 地域別セグメント分析 2019-2023
  • 国別セグメント分析 2019-2023

第6章 定性分析

  • AIの影響：慢性閉塞性肺疾患（COPD）治療薬の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：製品別

  • 市場セグメント
  • 比較：製品別
  • 併用療法：市場規模と予測 2024-2029
  • 単剤療法：市場規模と予測 2024-2029
  • 市場機会：製品別

第9章 市場セグメンテーション：流通チャネル別

  • 市場セグメント
  • 比較：流通チャネル別
  • 病院薬局：市場規模と予測 2024-2029
  • 小売薬局：市場規模と予測 2024-2029
  • オンライン薬局：市場規模と予測 2024-2029
  • 市場機会：流通チャネル別

第10章 市場セグメンテーション：投与経路別

  • 市場セグメント
  • 比較：投与経路別
  • 吸入：市場規模と予測 2024-2029
  • 経口：市場規模と予測 2024-2029
  • 注射：市場規模と予測 2024-2029
  • 市場機会：投与経路別

第11章 市場セグメンテーション：疾患タイプ別

  • 市場セグメント
  • 比較：疾患タイプ別
  • 慢性気管支炎：市場規模と予測 2024-2029
  • 肺気腫：市場規模と予測 2024-2029
  • 市場機会：疾患タイプ別

第12章 顧客情勢

  • 顧客情勢の概要

第13章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測 2024-2029
  • 欧州：市場規模と予測 2024-2029
  • アジア：市場規模と予測 2024-2029
  • 世界のその他の地域：市場規模と予測 2024-2029
  • 米国：市場規模と予測 2024-2029
  • カナダ：市場規模と予測 2024-2029
  • ドイツ：市場規模と予測 2024-2029
  • 中国：市場規模と予測 2024-2029
  • フランス：市場規模と予測 2024-2029
  • 英国：市場規模と予測 2024-2029
  • 日本：市場規模と予測 2024-2029
  • スペイン：市場規模と予測 2024-2029
  • ブラジル：市場規模と予測 2024-2029
  • オランダ：市場規模と予測 2024-2029
  • 市場機会：地域情勢別

第14章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第15章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第16章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • AstraZeneca Plc
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Ltd.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Innoviva Inc.
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • SHIONOGI Co. Ltd.
  • Sumitomo Pharma Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Theravance Biopharma Inc.
  • Viatris Inc.

第17章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits8: Executive Summary - Chart on Market Segmentation by Disease Type
  • Exhibits9: Executive Summary - Chart on Incremental Growth
  • Exhibits10: Executive Summary - Data Table on Incremental Growth
  • Exhibits11: Executive Summary - Chart on Company Market Positioning
  • Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits13: Overview on criticality of inputs and factors of differentiation
  • Exhibits14: Overview on factors of disruption
  • Exhibits15: Impact of drivers and challenges in 2024 and 2029
  • Exhibits16: Parent Market
  • Exhibits17: Data Table on - Parent Market
  • Exhibits18: Market characteristics analysis
  • Exhibits19: Value chain analysis
  • Exhibits20: Offerings of companies included in the market definition
  • Exhibits21: Market segments
  • Exhibits22: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits24: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits26: Historic Market Size - Data Table on Global Chronic Obstructive Pulmonary Disease Drugs Market 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
  • Exhibits31: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits32: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits33: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits34: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits37: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits38: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits39: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits40: Chart on Product - Market share 2024-2029 (%)
  • Exhibits41: Data Table on Product - Market share 2024-2029 (%)
  • Exhibits42: Chart on Comparison by Product
  • Exhibits43: Data Table on Comparison by Product
  • Exhibits44: Chart on Combination therapy - Market size and forecast 2024-2029 ($ million)
  • Exhibits45: Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million)
  • Exhibits46: Chart on Combination therapy - Year-over-year growth 2024-2029 (%)
  • Exhibits47: Data Table on Combination therapy - Year-over-year growth 2024-2029 (%)
  • Exhibits48: Chart on Monotherapy - Market size and forecast 2024-2029 ($ million)
  • Exhibits49: Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million)
  • Exhibits50: Chart on Monotherapy - Year-over-year growth 2024-2029 (%)
  • Exhibits51: Data Table on Monotherapy - Year-over-year growth 2024-2029 (%)
  • Exhibits52: Market opportunity by Product ($ million)
  • Exhibits53: Data Table on Market opportunity by Product ($ million)
  • Exhibits54: Chart on Distribution Channel - Market share 2024-2029 (%)
  • Exhibits55: Data Table on Distribution Channel - Market share 2024-2029 (%)
  • Exhibits56: Chart on Comparison by Distribution Channel
  • Exhibits57: Data Table on Comparison by Distribution Channel
  • Exhibits58: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
  • Exhibits59: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
  • Exhibits60: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
  • Exhibits61: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
  • Exhibits62: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
  • Exhibits63: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
  • Exhibits64: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
  • Exhibits65: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
  • Exhibits66: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
  • Exhibits67: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
  • Exhibits68: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
  • Exhibits69: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
  • Exhibits70: Market opportunity by Distribution Channel ($ million)
  • Exhibits71: Data Table on Market opportunity by Distribution Channel ($ million)
  • Exhibits72: Chart on Route of Administration - Market share 2024-2029 (%)
  • Exhibits73: Data Table on Route of Administration - Market share 2024-2029 (%)
  • Exhibits74: Chart on Comparison by Route of Administration
  • Exhibits75: Data Table on Comparison by Route of Administration
  • Exhibits76: Chart on Inhalation - Market size and forecast 2024-2029 ($ million)
  • Exhibits77: Data Table on Inhalation - Market size and forecast 2024-2029 ($ million)
  • Exhibits78: Chart on Inhalation - Year-over-year growth 2024-2029 (%)
  • Exhibits79: Data Table on Inhalation - Year-over-year growth 2024-2029 (%)
  • Exhibits80: Chart on Oral - Market size and forecast 2024-2029 ($ million)
  • Exhibits81: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  • Exhibits82: Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Exhibits83: Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • Exhibits84: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
  • Exhibits85: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
  • Exhibits86: Chart on Injectable - Year-over-year growth 2024-2029 (%)
  • Exhibits87: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
  • Exhibits88: Market opportunity by Route of Administration ($ million)
  • Exhibits89: Data Table on Market opportunity by Route of Administration ($ million)
  • Exhibits90: Chart on Disease Type - Market share 2024-2029 (%)
  • Exhibits91: Data Table on Disease Type - Market share 2024-2029 (%)
  • Exhibits92: Chart on Comparison by Disease Type
  • Exhibits93: Data Table on Comparison by Disease Type
  • Exhibits94: Chart on Chronic bronchitis - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Data Table on Chronic bronchitis - Market size and forecast 2024-2029 ($ million)
  • Exhibits96: Chart on Chronic bronchitis - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Data Table on Chronic bronchitis - Year-over-year growth 2024-2029 (%)
  • Exhibits98: Chart on Emphysema - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Data Table on Emphysema - Market size and forecast 2024-2029 ($ million)
  • Exhibits100: Chart on Emphysema - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Data Table on Emphysema - Year-over-year growth 2024-2029 (%)
  • Exhibits102: Market opportunity by Disease Type ($ million)
  • Exhibits103: Data Table on Market opportunity by Disease Type ($ million)
  • Exhibits104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits105: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits107: Chart on Geographic comparison
  • Exhibits108: Data Table on Geographic comparison
  • Exhibits109: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits158: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits159: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits160: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits161: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
  • Exhibits162: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
  • Exhibits163: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
  • Exhibits164: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
  • Exhibits165: Market opportunity By Geographical Landscape ($ million)
  • Exhibits166: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits167: Impact of drivers and challenges in 2024 and 2029
  • Exhibits168: Overview on criticality of inputs and factors of differentiation
  • Exhibits169: Overview on factors of disruption
  • Exhibits170: Impact of key risks on business
  • Exhibits171: Companies covered
  • Exhibits172: Company ranking index
  • Exhibits173: Matrix on companies position and classification
  • Exhibits174: AstraZeneca Plc - Overview
  • Exhibits175: AstraZeneca Plc - Product / Service
  • Exhibits176: AstraZeneca Plc - Key news
  • Exhibits177: AstraZeneca Plc - Key offerings
  • Exhibits178: SWOT
  • Exhibits179: Boehringer Ingelheim International GmbH - Overview
  • Exhibits180: Boehringer Ingelheim International GmbH - Product / Service
  • Exhibits181: Boehringer Ingelheim International GmbH - Key news
  • Exhibits182: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits183: SWOT
  • Exhibits184: Cadila Pharmaceuticals Ltd. - Overview
  • Exhibits185: Cadila Pharmaceuticals Ltd. - Product / Service
  • Exhibits186: Cadila Pharmaceuticals Ltd. - Key offerings
  • Exhibits187: SWOT
  • Exhibits188: Cipla Inc. - Overview
  • Exhibits189: Cipla Inc. - Business segments
  • Exhibits190: Cipla Inc. - Key news
  • Exhibits191: Cipla Inc. - Key offerings
  • Exhibits192: Cipla Inc. - Segment focus
  • Exhibits193: SWOT
  • Exhibits194: GlaxoSmithKline Plc - Overview
  • Exhibits195: GlaxoSmithKline Plc - Business segments
  • Exhibits196: GlaxoSmithKline Plc - Key news
  • Exhibits197: GlaxoSmithKline Plc - Key offerings
  • Exhibits198: GlaxoSmithKline Plc - Segment focus
  • Exhibits199: SWOT
  • Exhibits200: Glenmark Pharmaceuticals Ltd. - Overview
  • Exhibits201: Glenmark Pharmaceuticals Ltd. - Product / Service
  • Exhibits202: Glenmark Pharmaceuticals Ltd. - Key offerings
  • Exhibits203: SWOT
  • Exhibits204: Innoviva Inc. - Overview
  • Exhibits205: Innoviva Inc. - Product / Service
  • Exhibits206: Innoviva Inc. - Key news
  • Exhibits207: Innoviva Inc. - Key offerings
  • Exhibits208: SWOT
  • Exhibits209: Lupin Ltd. - Overview
  • Exhibits210: Lupin Ltd. - Business segments
  • Exhibits211: Lupin Ltd. - Key news
  • Exhibits212: Lupin Ltd. - Key offerings
  • Exhibits213: Lupin Ltd. - Segment focus
  • Exhibits214: SWOT
  • Exhibits215: Merck and Co. Inc. - Overview
  • Exhibits216: Merck and Co. Inc. - Business segments
  • Exhibits217: Merck and Co. Inc. - Key news
  • Exhibits218: Merck and Co. Inc. - Key offerings
  • Exhibits219: Merck and Co. Inc. - Segment focus
  • Exhibits220: SWOT
  • Exhibits221: Novartis AG - Overview
  • Exhibits222: Novartis AG - Business segments
  • Exhibits223: Novartis AG - Key news
  • Exhibits224: Novartis AG - Key offerings
  • Exhibits225: Novartis AG - Segment focus
  • Exhibits226: SWOT
  • Exhibits227: SHIONOGI Co. Ltd. - Overview
  • Exhibits228: SHIONOGI Co. Ltd. - Product / Service
  • Exhibits229: SHIONOGI Co. Ltd. - Key offerings
  • Exhibits230: SWOT
  • Exhibits231: Sumitomo Pharma Co. Ltd. - Overview
  • Exhibits232: Sumitomo Pharma Co. Ltd. - Business segments
  • Exhibits233: Sumitomo Pharma Co. Ltd. - Key offerings
  • Exhibits234: Sumitomo Pharma Co. Ltd. - Segment focus
  • Exhibits235: SWOT
  • Exhibits236: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits237: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits238: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits239: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits240: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits241: SWOT
  • Exhibits242: Theravance Biopharma Inc. - Overview
  • Exhibits243: Theravance Biopharma Inc. - Product / Service
  • Exhibits244: Theravance Biopharma Inc. - Key offerings
  • Exhibits245: SWOT
  • Exhibits246: Viatris Inc. - Overview
  • Exhibits247: Viatris Inc. - Business segments
  • Exhibits248: Viatris Inc. - Key news
  • Exhibits249: Viatris Inc. - Key offerings
  • Exhibits250: Viatris Inc. - Segment focus
  • Exhibits251: SWOT
  • Exhibits252: Inclusions checklist
  • Exhibits253: Exclusions checklist
  • Exhibits254: Currency conversion rates for US$
  • Exhibits255: Research methodology
  • Exhibits256: Information sources
  • Exhibits257: Data validation
  • Exhibits258: Validation techniques employed for market sizing
  • Exhibits259: Data synthesis
  • Exhibits260: 360 degree market analysis
  • Exhibits261: List of abbreviations
目次
Product Code: IRTNTR70733

The chronic obstructive pulmonary disease drugs market is forecasted to grow by USD 7,841 mn during 2024-2029, accelerating at a CAGR of 6.4% during the forecast period. The report on the chronic obstructive pulmonary disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of copd, strong pipeline and new drug approvals, and growing demand for fixed-dose combinations.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20255.8%
CAGR6.4%
Incremental Value$7,841 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's chronic obstructive pulmonary disease drugs market is segmented as below:

By Product

    • Combination therapy
    • Monotherapy

By Distribution Channel

    • Hospital pharmacies
    • Retail pharmacies
    • Online pharmacies

By Route Of Administration

    • Inhalation
    • Oral
    • Injectable

By Disease Type

    • Chronic bronchitis
    • Emphysema

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the expanding research in curative approaches as one of the prime reasons driving the chronic obstructive pulmonary disease drugs market growth during the next few years. Also, advances in drug delivery devices and expansion of inhalation therapies will lead to sizable demand in the market.

The report on the chronic obstructive pulmonary disease drugs market covers the following areas:

    • Chronic Obstructive Pulmonary Disease Drugs Market sizing
    • Chronic Obstructive Pulmonary Disease Drugs Market forecast
    • Chronic Obstructive Pulmonary Disease Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic obstructive pulmonary disease drugs market vendors that include AstraZeneca Plc, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CHIESI Farmaceutici SpA, Cipla Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Innoviva Inc., Lupin Ltd., Merck and Co. Inc., Novartis AG, SHIONOGI Co. Ltd., Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Theravance Biopharma Inc., Viatris Inc., and Phillips Medisize. Also, the chronic obstructive pulmonary disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by Distribution Channel
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Market Segmentation by Disease Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Chronic Obstructive Pulmonary Disease Drugs Market 2019 - 2023
    • Historic Market Size - Data Table on Global Chronic Obstructive Pulmonary Disease Drugs Market 2019 - 2023 ($ million)
  • 5.2 Product segment analysis 2019 - 2023
    • Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • 5.3 Distribution Channel segment analysis 2019 - 2023
    • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
  • 5.4 Route of Administration segment analysis 2019 - 2023
    • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • 5.5 Disease Type segment analysis 2019 - 2023
    • Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
  • 5.6 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.7 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The AI impact on Global Chronic Obstructive Pulmonary Disease Drugs Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

  • 8.1 Market segments
    • Chart on Product - Market share 2024-2029 (%)
    • Data Table on Product - Market share 2024-2029 (%)
  • 8.2 Comparison by Product
    • Chart on Comparison by Product
    • Data Table on Comparison by Product
  • 8.3 Combination therapy - Market size and forecast 2024-2029
    • Chart on Combination therapy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million)
    • Chart on Combination therapy - Year-over-year growth 2024-2029 (%)
    • Data Table on Combination therapy - Year-over-year growth 2024-2029 (%)
  • 8.4 Monotherapy - Market size and forecast 2024-2029
    • Chart on Monotherapy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million)
    • Chart on Monotherapy - Year-over-year growth 2024-2029 (%)
    • Data Table on Monotherapy - Year-over-year growth 2024-2029 (%)
  • 8.5 Market opportunity by Product
    • Market opportunity by Product ($ million)
    • Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Distribution Channel

  • 9.1 Market segments
    • Chart on Distribution Channel - Market share 2024-2029 (%)
    • Data Table on Distribution Channel - Market share 2024-2029 (%)
  • 9.2 Comparison by Distribution Channel
    • Chart on Comparison by Distribution Channel
    • Data Table on Comparison by Distribution Channel
  • 9.3 Hospital pharmacies - Market size and forecast 2024-2029
    • Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
  • 9.4 Retail pharmacies - Market size and forecast 2024-2029
    • Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
    • Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
    • Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
  • 9.5 Online pharmacies - Market size and forecast 2024-2029
    • Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
    • Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
    • Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by Distribution Channel
    • Market opportunity by Distribution Channel ($ million)
    • Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Route of Administration

  • 10.1 Market segments
    • Chart on Route of Administration - Market share 2024-2029 (%)
    • Data Table on Route of Administration - Market share 2024-2029 (%)
  • 10.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 10.3 Inhalation - Market size and forecast 2024-2029
    • Chart on Inhalation - Market size and forecast 2024-2029 ($ million)
    • Data Table on Inhalation - Market size and forecast 2024-2029 ($ million)
    • Chart on Inhalation - Year-over-year growth 2024-2029 (%)
    • Data Table on Inhalation - Year-over-year growth 2024-2029 (%)
  • 10.4 Oral - Market size and forecast 2024-2029
    • Chart on Oral - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
    • Chart on Oral - Year-over-year growth 2024-2029 (%)
    • Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • 10.5 Injectable - Market size and forecast 2024-2029
    • Chart on Injectable - Market size and forecast 2024-2029 ($ million)
    • Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
    • Chart on Injectable - Year-over-year growth 2024-2029 (%)
    • Data Table on Injectable - Year-over-year growth 2024-2029 (%)
  • 10.6 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ million)
    • Data Table on Market opportunity by Route of Administration ($ million)

11 Market Segmentation by Disease Type

  • 11.1 Market segments
    • Chart on Disease Type - Market share 2024-2029 (%)
    • Data Table on Disease Type - Market share 2024-2029 (%)
  • 11.2 Comparison by Disease Type
    • Chart on Comparison by Disease Type
    • Data Table on Comparison by Disease Type
  • 11.3 Chronic bronchitis - Market size and forecast 2024-2029
    • Chart on Chronic bronchitis - Market size and forecast 2024-2029 ($ million)
    • Data Table on Chronic bronchitis - Market size and forecast 2024-2029 ($ million)
    • Chart on Chronic bronchitis - Year-over-year growth 2024-2029 (%)
    • Data Table on Chronic bronchitis - Year-over-year growth 2024-2029 (%)
  • 11.4 Emphysema - Market size and forecast 2024-2029
    • Chart on Emphysema - Market size and forecast 2024-2029 ($ million)
    • Data Table on Emphysema - Market size and forecast 2024-2029 ($ million)
    • Chart on Emphysema - Year-over-year growth 2024-2029 (%)
    • Data Table on Emphysema - Year-over-year growth 2024-2029 (%)
  • 11.5 Market opportunity by Disease Type
    • Market opportunity by Disease Type ($ million)
    • Data Table on Market opportunity by Disease Type ($ million)

12 Customer Landscape

  • 12.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

  • 13.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 13.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 13.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 13.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 13.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 13.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 13.8 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 13.9 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 13.10 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 13.11 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 13.12 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 13.13 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 13.14 Spain - Market size and forecast 2024-2029
    • Chart on Spain - Market size and forecast 2024-2029 ($ million)
    • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
    • Chart on Spain - Year-over-year growth 2024-2029 (%)
    • Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • 13.15 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 13.16 The Netherlands - Market size and forecast 2024-2029
    • Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
    • Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
    • Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
    • Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
  • 13.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

14 Drivers, Challenges, and Opportunity/Restraints

  • 14.1 Market drivers
  • 14.2 Market challenges
  • 14.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 14.4 Market opportunities/restraints

15 Competitive Landscape

  • 15.1 Overview
  • 15.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 15.3 Landscape disruption
    • Overview on factors of disruption
  • 15.4 Industry risks
    • Impact of key risks on business

16 Competitive Analysis

  • 16.1 Companies profiled
    • Companies covered
  • 16.2 Company ranking index
    • Company ranking index
  • 16.3 Market positioning of companies
    • Matrix on companies position and classification
  • 16.4 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
    • SWOT
  • 16.5 Boehringer Ingelheim International GmbH
    • Boehringer Ingelheim International GmbH - Overview
    • Boehringer Ingelheim International GmbH - Product / Service
    • Boehringer Ingelheim International GmbH - Key news
    • Boehringer Ingelheim International GmbH - Key offerings
    • SWOT
  • 16.6 Cadila Pharmaceuticals Ltd.
    • Cadila Pharmaceuticals Ltd. - Overview
    • Cadila Pharmaceuticals Ltd. - Product / Service
    • Cadila Pharmaceuticals Ltd. - Key offerings
    • SWOT
  • 16.7 Cipla Inc.
    • Cipla Inc. - Overview
    • Cipla Inc. - Business segments
    • Cipla Inc. - Key news
    • Cipla Inc. - Key offerings
    • Cipla Inc. - Segment focus
    • SWOT
  • 16.8 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 16.9 Glenmark Pharmaceuticals Ltd.
    • Glenmark Pharmaceuticals Ltd. - Overview
    • Glenmark Pharmaceuticals Ltd. - Product / Service
    • Glenmark Pharmaceuticals Ltd. - Key offerings
    • SWOT
  • 16.10 Innoviva Inc.
    • Innoviva Inc. - Overview
    • Innoviva Inc. - Product / Service
    • Innoviva Inc. - Key news
    • Innoviva Inc. - Key offerings
    • SWOT
  • 16.11 Lupin Ltd.
    • Lupin Ltd. - Overview
    • Lupin Ltd. - Business segments
    • Lupin Ltd. - Key news
    • Lupin Ltd. - Key offerings
    • Lupin Ltd. - Segment focus
    • SWOT
  • 16.12 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
    • SWOT
  • 16.13 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 16.14 SHIONOGI Co. Ltd.
    • SHIONOGI Co. Ltd. - Overview
    • SHIONOGI Co. Ltd. - Product / Service
    • SHIONOGI Co. Ltd. - Key offerings
    • SWOT
  • 16.15 Sumitomo Pharma Co. Ltd.
    • Sumitomo Pharma Co. Ltd. - Overview
    • Sumitomo Pharma Co. Ltd. - Business segments
    • Sumitomo Pharma Co. Ltd. - Key offerings
    • Sumitomo Pharma Co. Ltd. - Segment focus
    • SWOT
  • 16.16 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus
    • SWOT
  • 16.17 Theravance Biopharma Inc.
    • Theravance Biopharma Inc. - Overview
    • Theravance Biopharma Inc. - Product / Service
    • Theravance Biopharma Inc. - Key offerings
    • SWOT
  • 16.18 Viatris Inc.
    • Viatris Inc. - Overview
    • Viatris Inc. - Business segments
    • Viatris Inc. - Key news
    • Viatris Inc. - Key offerings
    • Viatris Inc. - Segment focus
    • SWOT

17 Appendix

  • 17.1 Scope of the report
  • 17.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 17.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 17.4 Research methodology
    • Research methodology
  • 17.5 Data procurement
    • Information sources
  • 17.6 Data validation
    • Data validation
  • 17.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 17.8 Data synthesis
    • Data synthesis
  • 17.9 360 degree market analysis
    • 360 degree market analysis
  • 17.10 List of abbreviations
    • List of abbreviations